Geode Capital Management’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-52,333
Closed -$68K 4107
2016
Q2
$68K Hold
52,333
﹤0.01% 3878
2016
Q1
$70 Hold
52,333
﹤0.01% 3911
2015
Q4
$74K Hold
52,333
﹤0.01% 3944
2015
Q3
$81K Hold
52,333
﹤0.01% 3939
2015
Q2
$87K Hold
52,333
﹤0.01% 3801
2015
Q1
$111K Hold
52,333
﹤0.01% 3741
2014
Q4
$70K Hold
52,333
﹤0.01% 3840
2014
Q3
$43K Buy
52,333
+31,559
+152% +$56.8K ﹤0.01% 3848
2014
Q2
$46K Sell
20,774
-1,522
-7% -$3.78K ﹤0.01% 3785
2014
Q1
$66K Sell
22,296
-2,563
-10% -$8.44K ﹤0.01% 3728
2013
Q4
$78K Buy
24,859
+149
+0.6% +$416 ﹤0.01% 3640
2013
Q3
$68K Buy
24,710
+12,954
+110% +$35.1K ﹤0.01% 3542
2013
Q2
$29K Buy
+11,756
New +$61.6K ﹤0.01% 3571

Other funds holding ECTE

Geode Capital Management's ECTE Position: Q3 2016 in Review

Geode Capital Management sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2016, closing a stake of 52,333 shares — an estimated $68K sold.

Geode Capital Management first reported a position in ECTE in Q2 2013 and held it in 13 quarters. The position peaked at $111K in Q1 2015. 2 funds tracked by Wall St. Rank hold ECTE as of Q3 2016.

  • Geode Capital Management reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2016 after selling out during the quarter.
  • Geode Capital Management sold 52,333 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2016, an estimated $68K.
  • Geode Capital Management first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 13 quarters.
  • Geode Capital Management's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $111K in Q1 2015.
  • 2 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2016.

Based on Geode Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.